Bruno C. Antunes

Piraquara, PR 83302200, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding.

Immunogenic Potential of Selected Peptides from SARS-CoV-2 Proteins and Their Ability to Block S1/ACE-2 Binding.

Journal: Viruses

Published: September 30, 2024

Novel insights into the application of recombinant mutated phospholipases D as antigens for developing new strategies against Loxoscelism.

Novel insights into the application of recombinant mutated phospholipases D as antigens for developing new strategies against Loxoscelism.

Journal: Acta tropica

Published: June 10, 2024

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production.

The Health Status of Horses Used for at Least Six Complete Cycles of Loxoscelic Antivenom Production.

Journal: Toxins

Published: August 04, 2023

Production and Functional Evaluation of Anti-Loxosceles Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D.

Production and Functional Evaluation of Anti-Loxosceles Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D.

Journal: Biomedicines

Published: September 23, 2022

The major role of junctional diversity in the horse antibody repertoire.

The major role of junctional diversity in the horse antibody repertoire.

Journal: Molecular immunology

Published: June 26, 2022

Clinical Effects of the Immunization Protocol Using Loxosceles Venom in Naïve Horses.

Clinical Effects of the Immunization Protocol Using Loxosceles Venom in Naïve Horses.

Journal: Toxins

Published: April 19, 2022

A protective vaccine against the toxic activities following Brown spider accidents based on recombinant mutated phospholipases D as antigens.

A protective vaccine against the toxic activities following Brown spider accidents based on recombinant mutated phospholipases D as antigens.

Journal: International journal of biological macromolecules

Published: August 09, 2021

Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Journal: Frontiers in molecular biosciences

Published: May 07, 2021

Brown Spiders' Phospholipases-D with Potential Therapeutic Applications: Functional Assessment of Mutant Isoforms.

Brown Spiders' Phospholipases-D with Potential Therapeutic Applications: Functional Assessment of Mutant Isoforms.

Journal: Biomedicines

Published: December 22, 2020

Production of a novel recombinant brown spider hyaluronidase in baculovirus-infected insect cells.

Production of a novel recombinant brown spider hyaluronidase in baculovirus-infected insect cells.

Journal: Enzyme and microbial technology

Published: July 24, 2020

Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Journal: Toxins

Published: February 12, 2020

Next-generation sequencing reveals new insights about gene usage and CDR-H3 composition in the horse antibody repertoire.

Next-generation sequencing reveals new insights about gene usage and CDR-H3 composition in the horse antibody repertoire.

Journal: Molecular immunology

Published: August 10, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026